- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 13.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.82M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 4.54M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $10.54M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $5.93M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $7.7M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.22M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $182.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $207.36M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $116.22M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $115.6M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $62.96M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $64.48M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $187.9M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $168.51M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $42.53M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $37.75M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $370.08M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $375.87M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.28 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.28 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.11M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.6M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$25.63M |
| Net Income | Q1 2026 · Mar 31, 2025 | $140K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $6.7M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $150K |
| Revenue | Q1 2026 · Mar 31, 2026 | $40.22M |
| Revenue | Q1 2026 · Mar 31, 2025 | $8.74M |